Merkel cell carcinoma: mitoses, expression of Ki‐67 and bcl‐2 correlate with disease progression. (4th August 2014)
- Record Type:
- Journal Article
- Title:
- Merkel cell carcinoma: mitoses, expression of Ki‐67 and bcl‐2 correlate with disease progression. (4th August 2014)
- Main Title:
- Merkel cell carcinoma: mitoses, expression of Ki‐67 and bcl‐2 correlate with disease progression
- Authors:
- Vujic, I.
Marker, M.
Posch, C.
Mühlehner, D.
Monshi, B.
Breier, F.
Steiner, A.
Ortiz‐Urda, S.
Rappersberger, K. - Abstract:
- <abstract abstract-type="main" id="jdv12626-abs-0001"> <title>Abstract</title> <sec id="jdv12626-sec-0001" sec-type="section"> <title>Background</title> <p>There are conflicting data on markers of disease progression and outcome of Merkel cell carcinoma.</p> </sec> <sec id="jdv12626-sec-0002" sec-type="section"> <title>Objective</title> <p>We suggest to review histological and various immunohistochemical features of Merkel cell carcinoma specimens, in order to identify prognostic markers of clinical relevance.</p> </sec> <sec id="jdv12626-sec-0003" sec-type="section"> <title>Methods</title> <p>We collected paraffin‐embedded blocks from primary tumours from 26 patients diagnosed with Merkel cell carcinoma and determined the following: type and size of the tumour, number of mitoses, proliferation rate (Ki‐67 antibody), (anti)‐apoptosis rate (bcl‐2, p53, p63 antibodies) and lymphatic vessel invasion (D2‐40 antibody for podoplanin). Two authors blinded to clinical outcome, independently assessed and scored all samples. The findings were correlated with tumour progression, which was determined by local recurrence, lymph node‐ or distant metastases.</p> </sec> <sec id="jdv12626-sec-0004" sec-type="section"> <title>Results</title> <p>During the average follow‐up period of 63.4 months 12 (46%) patients had disease progression. Statistical analysis revealed Ki‐67‐staining (<italic>P</italic> = 0.005) as a marker of disease progression, high number of mitoses<abstract abstract-type="main" id="jdv12626-abs-0001"> <title>Abstract</title> <sec id="jdv12626-sec-0001" sec-type="section"> <title>Background</title> <p>There are conflicting data on markers of disease progression and outcome of Merkel cell carcinoma.</p> </sec> <sec id="jdv12626-sec-0002" sec-type="section"> <title>Objective</title> <p>We suggest to review histological and various immunohistochemical features of Merkel cell carcinoma specimens, in order to identify prognostic markers of clinical relevance.</p> </sec> <sec id="jdv12626-sec-0003" sec-type="section"> <title>Methods</title> <p>We collected paraffin‐embedded blocks from primary tumours from 26 patients diagnosed with Merkel cell carcinoma and determined the following: type and size of the tumour, number of mitoses, proliferation rate (Ki‐67 antibody), (anti)‐apoptosis rate (bcl‐2, p53, p63 antibodies) and lymphatic vessel invasion (D2‐40 antibody for podoplanin). Two authors blinded to clinical outcome, independently assessed and scored all samples. The findings were correlated with tumour progression, which was determined by local recurrence, lymph node‐ or distant metastases.</p> </sec> <sec id="jdv12626-sec-0004" sec-type="section"> <title>Results</title> <p>During the average follow‐up period of 63.4 months 12 (46%) patients had disease progression. Statistical analysis revealed Ki‐67‐staining (<italic>P</italic> = 0.005) as a marker of disease progression, high number of mitoses (<italic>P</italic> = 0.026) correlated with lymph node metastasis, while a tendency for increased Bcl‐2 expression (<italic>P</italic> = 0.064) was found in patients with local recurrence. A higher number of invaded lymphatic capillaries showed a tendency in correlation with metastases (<italic>P</italic> = 0.072).</p> </sec> <sec id="jdv12626-sec-0005" sec-type="section"> <title>Conclusion</title> <p>The findings indicate that high numbers of mitoses, proliferation and survival of tumour cells as marked by Ki‐67‐ and Bcl‐2‐staining, and infiltration of lymphatic vessels, might correlate with the biological behaviour of Merkel cell carcinoma.</p> </sec> </abstract> … (more)
- Is Part Of:
- Journal of the European Academy of Dermatology and Venereology. Volume 29:Number 3(2015:Mar.)
- Journal:
- Journal of the European Academy of Dermatology and Venereology
- Issue:
- Volume 29:Number 3(2015:Mar.)
- Issue Display:
- Volume 29, Issue 3 (2015)
- Year:
- 2015
- Volume:
- 29
- Issue:
- 3
- Issue Sort Value:
- 2015-0029-0003-0000
- Page Start:
- 542
- Page End:
- 548
- Publication Date:
- 2014-08-04
- Subjects:
- Dermatology -- Periodicals
Sexually transmitted diseases -- Periodicals
616.5 - Journal URLs:
- https://onlinelibrary.wiley.com/journal/14683083 ↗
http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=jdv ↗
http://www.sciencedirect.com/science/journal/09269959 ↗
http://onlinelibrary.wiley.com/ ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0926-9959;screen=info;ECOIP ↗
http://www.blackwell-synergy.com/loi/jdv ↗ - DOI:
- 10.1111/jdv.12626 ↗
- Languages:
- English
- ISSNs:
- 0926-9959
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4741.624000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3191.xml